<i>In vitro</i> Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes

DOI Web Site Web Site PubMed 8 References

Bibliographic Information

Other Title
  • In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes

Search this article

Abstract

We conducted antifungal susceptibility testing on itraconazole (ITCZ)-resistant isolates of Trichophyton interdigitale and Trichophyton rubrum collected from Japanese patients in 2021 and 2022. The aim of the present study was to determine the most effective drug against ITCZ-resistant strains of dermatophytes. In all isolates, the minimum inhibitory concentrations (MICs) were > 32 mg/l for ITCZ, < 0.03 to 0.5 mg/l for ravuconazole (RVCZ), and < 0.03 mg/l for efinaconazole (EFCZ), luliconazole (LUCZ), and terbinafine (TRBF). Thus, in tinea unguium cases with ITCZ-resistant strains, treatment should be switched to TRBF or other azoles with a stronger antifungal efficacy, such as EFCZ, LUCZ, or RVCZ, and treatment must continue until the infectious organisms are completely eliminated.

Journal

  • Medical Mycology Journal

    Medical Mycology Journal 64 (4), 103-105, 2023-10-31

    The Japanese Society for Medical Mycology

References(8)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top